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Abstract 
Foot-and-mouth disease (FMD) is endemic in Egypt and in most parts of Africa causing huge 
economic losses. Control of FMD using vaccination requires information on the occurrence of 
various FMDV serotypes. This study aimed to determine the prevalence of FMDV serotypes in 
Sharkia Governorate, Egypt. A total number of 643 different samples, within ten different 
localities, were collected from both cattle and buffaloes (n = 283) of different, age, sex, immune 
status against FMD, and health status. Field samples (n = 360) have been screened for FMDV by 
RT-PCR using universal primers and were further subtyped using serotype-specific primers. 
Additionally, serum samples (n = 283) have been analyzed by applying FMDV serotype-specific 
antibody ELISA. The RT-PCR screening revealed that a total number of 39/283 (13.8%), 61/283 
(21.6%) and 17/38 (44.7%) animals were positive for FMDV serotype O, A and SAT2, 
respectively. While, by ELISA, neutralizing antibodies directed against FMDV serotype O, A, 
and SAT2, were found in 177/283 (62.5%), 171/283 (60.4%) and 27/38 (71.1%) serum samples, 
respectively. These results indicated the endemic status of the FMDV serotypes O, A and SAT2 
in Sharkia Governorate despite routine FMD vaccination programs. Although many variations of 
disease prevalence were recorded between animals of different, age, sex and immune and health 
status but it was obvious that FMD was more prominent and prevalent in buffaloes (47.1%) than 
in cattle (34.1%). Therefore, control efforts should focus on reducing the circulation of FMDV 
among susceptible livestock with special attention towards water buffaloes. Continuous 
surveillance, at molecular and immunological levels, of FMDV serotypes is needed for the 
effectiveness of any adopted control strategy targeting FMD including vaccination. 
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Introduction 
Foot-and-mouth disease (FMD) is a highly 
contagious viral disease affecting both 
domestic and wild cloven-hoofed animals [1]. 
The FMD virus (FMDV) belongs to the genus 
Aphthovirus, the family Picornaviridae and 
the order Picornavirales [2]. The virus is 
highly mutable because its genome is 
composed of a linear, positive single-stranded 
RNA molecule with a quasispecies nature 
allowing the continuous evolution of new 
variants [3,4]. There are seven immunological 
distinct FMDV serotypes with multiple 
subtypes within each serotype (O, A, C, Asia 
1, South African Territories (SAT) 1, SAT 2, 
and SAT 3). With the exception of serotype C, 
FMDV serotypes are still circulating 
worldwide (Africa, Asia, west Eurasia, and 
South America) [5,6]. There is no antigenic 
relationship between the different FMDV 
serotypes, therefore, the cross-protection does 
not exist totally. Moreover, in many cases, the 
cross-protection between different subtypes of 
the same serotype fails to be induced [7]. 
Consequently, continuous updating of data 
regarding to the field circulating topotypes is 
necessary for appropriate vaccine manufacture 
and disease control [8,9]. 
In many developing countries including 
Egypt, FMD is endemic and considered as a 
major transboundary disease that causes great 
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limitations on sales and exports of livestock 
and livestock products [10, 11]. Serotype O 
was considered the predominant serotype in 
Egypt because it induced all outbreaks 
between 1964 and 2005 excluding an outbreak 
in 1972 that was caused by serotype A [12,13]. 
In 2006, Sharkia and many Egyptian 
Governorates were stroked by severe FMD 
outbreaks caused by serotype A [12,14]. 
Vaccination programs depending on locally 
produced bivalent vaccines, against both 
serotypes A and O, were applied however 
severe FMD outbreaks existed in February 
2012. Sharkia and Gharbia were the first 
Egyptian Governorates in which these 
outbreaks were recognized. Large numbers of 
cattle and water buffaloes showed severe 
clinical signs of FMD and a high mortality rate 
(up to 50%) particularly in young animals as a 
result of FMDV-induced myocarditis. An 
exotic FMDV serotype (SAT2) was the 
primary cause of the 2012- FMD epidemic in 
Egypt [15,16]. During 2012-2014, the three 
FMDV serotypes, O, A, and SAT2 were 
detected in many outbreaks among cattle and 
water buffaloes in Egypt [6]. 
The control of FMD is depending largely 
on the disease epidemiological data which in 
turn affected by many factors including the 
role of different susceptible hosts in disease 
transmissibility and persistency. In addition, 
the incursion of exotic viral strains in FMD 
endemic areas including Egypt has a great 
impact on the epidemiological map of the 
disease [10]. This study was carried out to 
generate data regarding the prevalence of 
FMDV serotypes in Sharkia Governorate, 
Egypt. For this reason, the different FMDV 
serotypes and their specific antibodies were 
tested in clinically sick and apparently healthy 
cattle and buffalos in different localities across 
Sharkia Governorate, Egypt.  
Material and methods 
Area and animals under investigation 
The study was conducted in Sharkia 
Governorate, Egypt during 2008-2015. 
Samples were collected randomly from both 
sick or apparently healthy cattle and buffaloes 
of different, ages (from 7 days to 6 years), 
sexes, and immune status (vaccinated and non-
vaccinated animals). The selected animals (n = 
283) were reared in villages/houses and farms 
that reported FMD outbreaks within ten 
cities/centers in Sharkia Governorate. A total 
number of 196 houses/farms (cattle = 56, 
buffalos = 99 and integrated rearing system of 
cattle and buffalos together = 41) were 
investigated (Figure 1 Upper panel). These 
localities had active FMD outbreaks 2 weeks 
to 8 months before sampling.  
Clinical specimens 
Clinical specimens were collected from 
animals with typical signs and lesions of FMD 
(Figure 1 Lower panel) and from apparently 
healthy animals during sampling. At sampling 
time, the owners of the farms/animals have 
been questioned in regard to their FMD 
vaccine practice.  
A total number of 360 field samples were 
collected from cattle and buffaloes. These 
samples comprised of 154 samples (88 mouth 
epithelia, 19 vesicular fluids, and 47 oral 
swabs) from cattle and buffaloes suspected of 
being infected with FMDV and 206 samples 
(87 oropharyngeal (OP) swabs, 82 fecal and 37 
milk samples) from apparently healthy 
animals. In addition, 283 blood samples were 
collected from cattle and buffaloes, of which, 
126 were collected from 33 sick and 93 
apparently healthy cattle. The remaining 157 
blood samples were collected from 88 sick and 
69 apparently healthy buffalos. The samples 
were used for preparation of sera to detect 
antibodies against FMDV serotypes (O, A and 
SAT2). 
Reverse transcription and Polymerase chain 
reaction 
Total RNA was extracted from the 
collected filed samples using the GeneJET 
RNA Purification Kit (Thermo scientific, EU) 
according to the manufacturer’s 
recommendations. The extracted RNA was 
examined firstly by RT-PCR using universal 
primers 1F/1R generating 328 bp product 
regardless of the serotype [17]. The RT-PCR 
was performed using VersoTM One Step RT-
PCR Kit (Thermo scientific, EU). The thermal 
profile was started at 50°C for30 min for 
reverse transcription; then PCR activation at 
76 
95°C for 15 min; followed by 35 cycles at 
94°C for 30 sec, 55°C for 30 sec, and 72°Cfor 
90 sec. Finally, the PCR reaction was 
completed at 72°C for 10 min and the PCR 
products were then analyzed by gel 
electrophoresis. For identifying the serotype in 
each of the FMDV PCR positive samples, 
another RT-PCR was performed using 
serotype-specific primers for serotypes O, A 
and SAT2 as previously described [17,18].  
Virus isolation on BHK-21 cells 
Positive serotype-specific RT-PCR samples 
for serotypes O, A and SAT2 were prepared 
for the isolation of FMDV according to the 
directions of OIE [19]. The prepared samples 
(150 µL) were added in a triplicate manner to 
pre-formed monolayers of baby hamster 
kidney-21 (BHK-21) cells grown in 24-well 
plates. The plates were incubated at 37°C for 1 
h, followed by change of media and continued 
incubation at 37°C for 4 days with daily 
observation for the development of cytopathic 
effect (CPE). The harvest of positive isolates 
was further tested by the serotype-specific RT-
PCR for the presence of FMDV. Aliquots of 
infected cell lysate of each sample were 
processed and used for coating ELISA plates 
[20] to be used for the detection of serotype 
specific antibodies.  
Serum antibody assay 
The collected serum samples were checked 
for specific antibodies against O, A, and SAT2 
serotypes of FMDV in enzyme-linked 
immunosorbent assay (ELISA) microtiter 
plates by the Solid Phase Blocking (SPB) 
indirect ELISA [20]. Each serum sample was 
run in duplicates; the tests were carried out on 
a screening basis at a dilution of 1/16. As 
controls, antigen, known positive and negative 
sera were included in each ELISA plate. 
Optical density (OD) values were determined 
using ELISA reader (Behring EL311) at a 
wave length of 492 nm.  The formula is as 
follows, where OD = optical density: 
                  OD sample – OD negative 
Value   = 
                 OD positive – OD negative 
 
Statistical analysis  
Prevalence of FMDV determined as the 
proportion of the samples in which infection 
was detected by RT-PCR. The statistical 
analysis for RT-PCR results was done using 
Chi-Square test in SPSS 11.0 software (SPSS 
Inc., Chicago, IL, USA).  The WinPepi 
software, Version 11.65 [21] was used for 
calculation of prevalence and 95% confidence 
interval (95% CI). The seropositivity rates 
were determined by dividing the total number 
of positive sera by the total number of tested 
samples and were expressed as a percentage.  
Results 
Clinical signs 
The clinical signs during the FMD 
epidemic among buffaloes included fever, 
anorexia, vesicles and ulcers in lips (Figure 1 
Lower panel A), tongue, gum with excessive 
salivation, and lameness. Same lesions were 
also observed in cattle in addition to ulcers in 
nostrils (Figure 1 Lower panel B). Some 
young animals exhibited diarrhea and sudden 
deaths without previous clinical signs, 
especially buffalo calves less than 1 month 
old. Others were clinically examined and 
showed a cardiac arrhythmia followed by 
respiratory distress and grunting just before 
death. At sampling time, mortality rates of 
21% and 18% were recorded among sick cattle 
and buffalos, respectively.  
Molecular detection of FMDV serotypes 
by RT-PCR 
The RT-PCR targeting 5' UTR, using 
universal primers, revealed 117 FMDV 
infected animals (Table 1) with an overall 
prevalence of 41.3% (117/283, 95% CI 
35.6%–47%). This percentage varied 
according to species, health status, locality, 
age, sex and immune status (Table 1). The 
FMDV detection rates in cattle and buffalos 
were 34.1% and 47.1%, respectively. FMDV 
was detected in 76% of sick and 15.4% of 
apparently healthy animals. There was a 
significant variation between the tested 
samples that were collected from diseased and 
apparently healthy animals. In sick animals, 
the FMDV was detected in 22/33 cattle and 
70/88 buffaloes with the percentages of 66.7% 
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and 79.5%, respectively. However, the 
apparently healthy animals that tested positive 
for FMDV were 21/93 cattle and 4/69 
buffaloes with the percentages of 22.6% and 
5.8%, respectively. 
According to the locality of sampling, the 
highest positivity rate of FMDV infection 
(83.3%) came from EL-Hosayneya, followed 
by Kafr Sakr (57.1%), Minet Elkamh (56.5%), 
Zagazig (48.1%) and Abu Kabier (45.5%)., 
The lowest detection rate was observed in 
Mashtul assuq (4.8%). The virus detection rate 
was significantly higher in animals older than 
one year than in younger animals (48.5% 
versus 24.7%, respectively. Regarding to 
gender, the virus detection rate in females 
(43.8%) was insignificantly higher than in 
males (32.2%). The non-vaccinated animals 
showed a higher detection rate of FMD 
(46.1%) than that of vaccinated ones (39.2%), 
however, this difference was non-significant.  
Table 1: Epidemiological data for FMDV infection in cattle and buffalos in Sharkia Governorate, Egypt  
Variable  Sample 
collected, No. 
(%) 
FMDV-positive 
samples, No. 
(%) 
p value 95% CI 
Species    0.027  
Cattle  126 (44.5%) 43 (34.1%)  25.9-43.1 
Buffalo  157 (55.5%) 74 (47.1%)  39.1-55.3 
Health status    <0.001  
Healthy 162 (57.2%) 25 (15.4%)  10.2-21.9 
Sick  121 (42.8%) 92 (76.0%)  67.4-83.3 
Sample type   <0.001  
Oral samples (mouth epithelium, 
vesicular fluid, oral swab) 
154 (42.8%) 116 (75.3%)  67.7-81.9 
OP (oropharyngeal) 87 (24.2%) 25 (28.7%)  19.5-39.4 
Feces 82 (22.8%) 0 (0)  0 
Milk 37 (10.3%) 1 (2.7%)  0-14.2 
Localities   <0.001  
Zagazig 81 (28.6%) 39 (48.1%)  36.9-59.5 
Minet Elkamh 46 (16.3%) 26 (56.5%)  41.1-71.1 
Abu-Hamad 35 (12.4%) 11 (31.4%)  16.9-49.3 
Fakus 15 (5.3%) 2 (13.3%)  1.7-40.5 
Belbis 23 (8.1%) 7 (30.4%)  13.2-52.9 
Hihya 20 (7.1%) 8 (40%)  19.1-63.9 
Abu Kabier 22 (7.8%) 10 (45.5%)  24.4-67.8 
Kafr Sakr 14 (4.9%) 8 (57.1%)  28.9-82.3 
El-Hosayneya 6 (2.1%) 5 (83.3%)  35.9-99.6 
Mashtul assuq 21 (7.4%) 1 (4.8%)  0.1-23.8 
Age (year)   <0.001  
≤ 1 year 85 (30.0%) 21 (24.7%)  15.9-35.3 
> 1 year 198 (70.0%) 96 (48.5%)  41.3-55.7 
Sex   0.1089  
Male  59 (20.8%) 19 (32.2%)  20.6-45.6 
Female  224 (79.2%) 98 (43.8%)  37.2-50.5 
Immune status   0.2733  
Vaccinated  194 (68.6%) 76 (39.2%)  32.3-46.4 
Non vaccinated 89 (31.4%) 41 (46.1%)  33.4-56.9 
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Table 2: Typing of FMDV in sick and apparently healthy cattle and buffalos 
Species Status Total No of 
samples 
No of positive (%) 
5`UTR O A SAT2* 
Cattle  Sick 33 22 (66.7) 5 (15.2) 14 (42.4) 3 (9.1) 
Apparently healthy 93 21 (22.6) 18 (19.4) 2 (2.2) 1 (1.1) 
Buffalo Sick 88 70 (79.5) 14 (15.9) 44 (50.0) 12 (13.6) 
Apparently healthy 69 4 (5.8) 2 (2.9) 1 (1.4) 1 (1.4) 
Total  283 117 (41.3) 39 (13.8) 61 (21.6) 17 (6.0) 
* Total number of samples collected after incursion of SAT2 in Egypt was 38. Number of positive SAT2 in those 
samples was 17/38 with a percentage of 44.7%.   
 
Typing of FMDV-positive samples using 
serotype-specific primers revealed FMDV 
serotypes O, A and SAT2 in 39 (13.8%), 61 
(21.6%) and 17 (6%) animals, respectively 
(Table 2). Moreover, the results indicated that 
all FMDV-positive samples were of the SAT2 
serotype (14/17) during outbreaks of 2012 and 
2013 with the percentage of 83.2%. The 
amplification products were identified at the 
expected positions of 328 bp for FMDV and 
1,301, 863-866 or 880 bp for O, A or SAT2, 
respectively (data not shown).  
Sero-prevalence 
Using SPB indirect ELISA method, specific 
antibodies against FMDV serotypes O, A and 
SAT2 were detected.  Specific FMDV 
serotype O antibodies were detected in 88 
(69.8%) cattle and 89 (56.7%) buffalo serum 
samples, respectively. Whereas, FMDV 
serotype A neutralizing antibodies were 
detected in 77 (61.1%) and 94 (59.9%) sera 
collected from cattle and buffalos, 
respectively. The specific antibodies against 
FMDV serotype SAT2 were detected in 20 
(83.3%) cattle and 7 (50%) buffalo serum 
samples. The sero-positivity of the FMDV 
serotypes O, A and SAT2 appeared also 
variable according to other four factors; health 
status, age, sex, and immune status (Figure 2). 
There were great variations in the sero-
positivity of the FMDV serotypes O, A and 
SAT2 in the different localities. For serotype 
A specific antibodies, the percentages of sero-
positivity ranged from 25% in Fakus and Kafr 
Sakr to 100% in El-Hosayneya. The highest 
seropositive results (83.3%) against FMDV 
serotype O were detected in cattle sera 
collected from Abu Kabier, while the lowest 
results were 18.8% in Abu-Hamad. In buffalo 
sera, the highest antibody prevalence (100%) 
for both FMDV serotype A and O was 
recorded in Belbis. No antibodies against 
serotype A were detected in sera collected 
from Fakus. The SAT2 specific antibodies was 
detected in, one (33.3%) serum sample from 
cattle and buffaloes in El-Hosayneya, and in 
19 (90.5%) serum samples from cattle and 6 
(54.5%) serum samples from buffaloes in 
Mashtul assuq and Minet Elkamh, respectively 
(Fig. 3). 
Discussion 
Since its first detection in 1964 among 
Egyptian livestock [22], FMD is being the 
most frequent endemic viral disease affecting 
the Egyptian animal industry causing drastic 
economic losses. Both FMDV serotypes O and 
A were the only serotypes incriminated in the 
disease endemicity in Egypt until 2011 
[12,15,23]. In February 2012, a different 
serotype, SAT2, was introduced causing an 
extensive FMD outbreak among Egyptian 
animals [16,24]. Up to date, several FMD 
outbreaks are still stroking the livestock in 
Egypt in spite of routine massive vaccination. 
This raises the question whether these 
outbreaks are caused by the same serotypes or 
by new one/s. Thereby, identification of 
circulating serotypes is essential and will aid 
in the proper vaccine choice and consequently 
reduce disease losses. Thus, at the 
immunological and molecular levels among 
clinically infected and apparently healthy 
Egyptian cattle and buffaloes in Sharkia 
Governorate were examined for the presence 
of FMDV infection.  
It has been reported that the infection in 
African buffalo with FMDV is almost sub-
clinical [25]. In this study, with the exception 
of one lesion (erosions or ulcers on the 
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nostrils, Figure 2B) which was observed only 
in many infected cattle, all clinically infected 
animals including buffaloes showed typical 
signs of FMD [26]. This assumes that water 
buffaloes are more susceptible to FMDV 
infection than African ones. Moreover, it was 
shown that water buffaloes are more resistant 
to FMDV infection and showed less signs and 
lesions than cattle [27]. However, in this study 
a total number of 70 (79.5%) buffaloes that 
tested positive for FMD showed moderate to 
severe typical clinical signs of the disease. In 
addition, the overall mortality rate among 
infected buffaloes (18%) was close to that of 
cattle (21%). This could be attributed to the 
adaptation of circulating FMDV serotypes to 
both animal species (cattle and buffalo) 
producing severe clinical signs [28,29].
 
 
 
Figure 1: Sites and animals investigated for FMDV infection in Sharkia Governorate, Egypt. Map of Egypt 
showing Sharkia Governorate (grey). The samples were collected from ten cities/centers within Sharkia 
Governorate, Egypt. Figure shows the number of investigated cattle- and buffalo- houses/farms per center 
(Upper panel). Clinical manifestation of animal suspected to be affected by FMDV, Sharkia Governorate. A) 
Blanching of epithelium after vesicle rupture on the upper lip of a buffalo. B) Erosion in the nostril of a cow 
(Lower panel). 
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Figure 2: Sero-prevalence of specific antibodies against FMDV serotypes, O, A and SAT2 in serum samples of 
cattle and buffaloes according to animal species, health status, age, sex, and immune status using indirect 
SPB ELISA. The Figure displays the sero-positivity percentages (columns) and 95% confidence interval; 
Lower confidence interval (l. CI) and upper confidence interval (u. CI) (lines). 
 
The molecular detection of FMDV among 
cattle and buffaloes using specific RT-PCR 
revealed a relatively high rate (41.3%) of 
active virus infection. The quasispecies nature 
of FMDV [3] along with inefficient routine 
vaccination may be implicated in such high 
infection rate. It was also reported that FMDV 
may circulate undetectable among vaccinated 
herds [30]. Further studies showed that 
experimental infection in non-vaccinated 
buffalos and cattle with FMDV induced more 
prominent clinical signs in buffaloes compared 
to cattle [28]. In our study, contrary to the 
apparently healthy buffaloes which showed 
lower percent (5.8%) of FMDV positive 
animals than apparently healthy cattle 
(22.6%), a higher proportion (79.5%) of 
FMDV positive animals were detected among 
symptomatic buffaloes compared to 
symptomatic cattle (66.7%) (Table 2). These 
results confirm that a higher percent of 
Egyptian water buffaloes rather than cattle 
escaped from vaccination or improperly 
vaccinated and became highly adapted to the 
circulating FMDV strains [29]. Most samples 
that tested positive for FMDV using RT-PCR 
were the oral samples (75.3%) and then the 
oropharyngeal (OP) swabs (28.7%) (Table 1). 
This indicates that most studied FMD infected 
animals were in the acute state of the disease 
whereas other animals were sub-clinically or 
persistently infected [13]. Only one milk 
sample (2.7%) tested positive for the presence 
of FMDV (Table 1). A possible explanation is 
that all the examined milk samples were 
collected from apparently healthy animals and 
there was no evidence for the persistence of 
FMDV in mammary tissue at 28 dpi [31].  In 
addition, all fecal samples were collected from 
apparently healthy animals and tested negative 
for FMDV, although some OP swabs from the 
same animals were positive. This assumes that 
the fecal sample is not ideal for the detection 
and consequently the surveillance of FMDV 
especially among sub-clinically or persistently 
infected cattle or buffaloes. The percent of 
FMD infected animals above 1 year age 
(48.5%) was nearly the double of those less 
than 1 year age (24.7%) (Table 1). This may 
be attributed to colostral antibodies which 
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protect animals up to 6 months of age which in 
turn decrease the rate of FMDV infection 
among calves of less than 1 year old [13]. 
However, most deaths were among animals 
less than 1 year age (data not shown). This 
could be attributed to that naïve calves develop 
more prominent clinical FMD signs and 
lesions than older animals including cardiac 
affections which are considered the main cause 
of high mortalities among younger animals 
[32]. This also highlights the importance of 
proper vaccination of the dams to protect their 
young calves. 
 
 
Figure 3: Sero-prevalence of specific antibodies against FMDV serotypes, A, O and SAT2 in serum samples of 
cattle (columns) and buffaloes (lines) in different localities within Sharkia Governorate using indirect SPB 
ELISA. The Figure displays the mean sero-positivity percentages ± standard error (Bars). 
 
The three FMDV serotypes, O, A, and 
SAT2 were identified in the examined samples 
using RT-PCR and indirect SPB ELISA (for 
antibody detection). By RT-PCR, our results 
revealed variable detection rates, ranged from 
4.8% to 83.3% among investigated localities 
(Table 1). In the same accordance, ELISA 
results showed antibodies against the three 
FMDV serotypes, O, A and SAT2, ranged 
from 18.8-100% and 0-100% in sera collected 
from cattle and buffaloes, respectively. These 
variations may be attributed to sample size and 
site, sampling time, age and sex and immune 
and health status of investigated animals 
particularly considering the intensive 
movement of animals and the lack of good 
hygiene and quarantine precautions especially 
during outbreaks [29]. By ELISA, the results 
demonstrated that the overall sero-prevalence 
of antibodies against FMDV serotype O and A 
was 69.8% and 56.7% in the examined cattle 
and buffalo populations, respectively. Specific 
FMDV serotype A neutralizing antibodies of 
61.1% and 59.9% were detected in cattle and 
buffalo sera, respectively. On the contrary, 
lower prevalence against the both serotypes 
was reported by detecting specific antibodies 
against FMDV serotypes A and O in 17.5% 
and 4.17% of apparently healthy bovine sera 
[33]. Those variations may be attributed to the 
difference in the method of ELISA used. The 
specific antibodies against FMDV serotype 
SAT2 were detected in 83.3% cattle and 50% 
buffalo serum samples. Similarly, Wekesa and 
his colleagues recorded the presence of SAT2 
neutralizing antibodies in 51.96% of African 
buffaloes [34]. In this study, 68.6% of all 
questioned owners vaccinated their animals. 
Of those, 11% were vaccinated their animals 
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on regular manner twice per year, whereas the 
majority of the owners vaccinated only the 
newly introduced animals. They administered 
the vaccine only once without any additional 
booster vaccination. Besides, the overall sero-
prevalence against FMDV serotype O, A, and 
SAT 2, was 62.5% (177/283), 60.4% 
(171/283) and 71.1% (27/38). Therefore, this 
does not essentially mean that the animals 
have acquired the immunity by becoming 
infected with each serotype. It may be 
suggested that those animals have been 
vaccinated with bi-or multi-valent vaccines, 
either after they have had an infection or the 
vaccine strain has not matched with the 
circulating one [35]. 
Conclusion 
In conclusion, the three serotypes of 
FMDV; O, A, and SAT 2 are constantly 
circulating among cattle and buffaloes in 
different localities within Sharkia 
Governorate, Egypt. For an effective and 
realizable FMD control program in Sharkia 
Governorate, Egypt, we suggest ensuring that 
mass vaccination covers all cattle and 
buffaloes twice annually at least, with special 
and district attention to animals in villages 
(house rearing). Those vaccinations should be 
administered along with the already individual 
performed vaccinations to provide a 
continuous high level of herd immunity.  
Conflict of interest 
The authors declare no conflicts of interest. 
Acknowledgments 
The authors would like to thank the 
Molecular Biology and Biotechnology 
Research Unit, Animal Wealth Development 
Department, Faculty of Veterinary Medicine, 
Zagazig University. 
References  
 [1] Davies, G. (2002): Foot and mouth 
disease. Res Vet Sci, 73(3): 195-199. 
[2] ICTV (2015): Virus Taxonomy: 2015 
Release. EC 47, London, UK, July 2015 
Available at: 
http://wwwictvonlineorg/virustaxonomyas
p. 
[3] Domingo, E.; Sheldon, J. and Perales, C. 
(2012): Viral quasispecies evolution. 
Microbiol Mol Biol Rev, 76(2): 159-216. 
[4] Domingo, E.; Escarmis, C.; Martinez, 
M.A.; Martinez-Salas, E. and Mateu, M.G. 
(1992): Foot-and-mouth disease virus 
populations are quasispecies. Curr Top 
Microbiol Immunol, 176: 33-47. 
[5] Mason, P.W.; Pacheco, J.M.; Zhao, Q.Z. 
and Knowles, N.J. (2003): Comparisons of 
the complete genomes of Asian, African 
and European isolates of a recent foot-and-
mouth disease virus type O pandemic 
strain (PanAsia). J Gen Virol, 84(6): 1583-
1593. 
[6] FAO (2015): Global Foot-and-Mouth 
Disease Situation, Food and Agriculture 
Organization of the United Nations, 
January 2015. 
[7] Jamal, S.M.; Ferrari, G.; Ahmed, S.; 
Normann, P. and Belsham, G.J. (2011): 
Molecular characterization of serotype 
Asia-1 foot-and-mouth disease viruses in 
Pakistan and Afghanistan; emergence of a 
new genetic Group and evidence for a 
novel recombinant virus. Infect Genet 
Evol, 11(8): 2049-2062. 
[8] Jamal, S.M.; Shah, S.I.; Ali, Q.; Mehmood, 
A.; Afzal, M.; Afzal, M. and Dekker, A. 
(2014): Proper quality control of 
formulated foot-and-mouth disease 
vaccines in countries with prophylactic 
vaccination is necessary. Transbound 
Emerg Dis, 61(6): 483-489. 
[9] Biswal, J.K.; Jena, S.; Mohapatra, J.K.; 
Bisht, P. and Pattnaik, B. (2014): Detection 
of antibodies specific for foot-and-mouth 
disease virus infection using indirect 
ELISA based on recombinant nonstructural 
protein 2B. Arch Virol, 159(7): 1641-1650. 
[10] Rweyemamu, M.; Roeder, P.; Mackay, 
D.; Sumption, K.; Brownlie, J.; 
Leforban, Y.; Valarcher, J. F.; Knowles, 
N. J. and Saraiva, V. (2008): 
Epidemiological patterns of foot-and-
mouth disease worldwide. Transbound 
Emerg Dis, 55(1): 57-72. 
83 
[11] Paton, D.J.; Sinclair, M. and Rodriguez, 
R. (2010): Qualitative assessment of the 
commodity risk for spread of foot-and-
mouth disease associated with 
international trade in deboned beef. 
Transbound Emerg Dis, 57(3): 115-134. 
[12] Knowles, N.J.; Wadsworth, J.; Reid, 
S.M.; Swabey, K.G.; El-Kholy, A.A.; 
Abd El-Rahman, A. O.; Soliman, H. M.; 
Ebert, K.; Ferris, N. P.; Hutchings, G. H.; 
Statham, R. J.; King, D. P. and Paton, D. 
J. (2007): Foot-and-mouth disease virus 
serotype A in Egypt. Emerg Infect Dis, 
13: 1593-1596. 
[13] OIE (2012): Manual of diagnostic tests 
and vaccines for terrestrial animals 2012. 
Paris:World Organisation for Animal 
Health. 
[14] Ghoneim, N.H.; Abdel-Karim, A.K.; El-
Shehawy, L. and Abdel-Moein, K.A. 
(2010): Foot and mouth disease in 
animals in Sharkia governorate - Egypt. 
Transbound Emerg Dis, 57(1-2): 19-21. 
[15] Ahmed, H.A., Salem, S.A.; Habashi, 
A.R.; Arafa, A.A.; Aggour, M.G.; Salem, 
G. H.; Gaber, A. S.; Selem, O.; 
Abdelkader, S. H.; Knowles, N. J.; Madi, 
M.; Valdazo-Gonzalez, B.; Wadsworth, 
J.; Hutchings, G. H.; Mioulet, V.; 
Hammond, J. M. and King, D. P. (2012): 
Emergence of foot-and-mouth disease 
virus SAT 2 in Egypt during 2012. 
Transbound Emerg Dis, 59(6): 476-481. 
[16] Kandeil, A.; El-Shesheny, R.; Kayali, G.; 
Moatasim, Y.; Bagato, O.; Darwish, M.; 
Gaffar, A.; Younes, A.; Farag, T.; 
Kutkat, M. A. and Ali, M. A. (2013): 
Characterization of the recent outbreak 
of foot-and-mouth disease virus serotype 
SAT2 in Egypt. Arch Virol, 158(3): 619-
627. 
[17] Reid, S.M.; Ferris, N.P.; Hutchings, G.H.; 
Samuel, A.R. and Knowles, N.J. (2000): 
Primary diagnosis of foot-and-mouth 
disease by reverse transcription 
polymerase chain reaction. J Virol 
Methods, 89(1): 167-176. 
[18] Bastos, A.D.; Haydon, D.T.; Sangare, O.; 
Boshoff, C.I.; Edrich, J.L. and Thomson, 
G.R. (2003): The implications of virus 
diversity within the SAT 2 serotype for 
control of foot-and-mouth disease in sub-
Saharan Africa. J Gen Virol, 84(6): 
1595-1606. 
[19] OIE (2000): Annual Status 2000. Foot 
and mouth disease, Chapter 2.1.1 in 
manual of standards for diagnostic tests 
and vaccine, 4th Ed., Paris. 77-92. 
 
[20] Chénard, G.; Miedema, K.; Moonen, P.; 
Schrijver, R.S. and Dekker, A. (2003): A 
solid-phase blocking ELISA for 
detection of type O foot-and-mouth 
disease virus antibodies suitable for mass 
serology. J Virol Methods, 107(1): 89-
98. 
[21] Abramson, J.H. (2011): WINPEPI 
updated: computer programs for 
epidemiologists, and their teaching 
potential. Epidemiol Perspect Innov, 
8(1): 1. 
[22] Moussa, A.A.M.; Daoud, A.; Hussein, K.; 
Fahmy, F.; El-Kilany, S. and El-
Shehawy, L.  (1979): Prevalence of FMD 
in Egypt. 14th Arab Veterinary 
Congress, 14: 39-50. 
[23] Knowles, N.J.; Nazem Shirazi, M.H.; 
Wadsworth, J.; Swabey, K.G.; Stirling, 
J.M.; Statham, R. J.; Li, Y.; Hutchings, 
G. H.; Ferris, N. P.; Parlak, U.; Ozyoruk, 
F.; Sumption, K. J.; King, D. P. and 
Paton, D. J. (2009): Recent spread of a 
new strain (A-Iran-05) of foot-and-
mouth disease virus type A in the Middle 
East. Transbound Emerg Dis, 56(5): 157-
169. 
[24] El-Shehawy, L.I.; Abu-Elnaga, H.I.; Rizk, 
S.A.; Abd El-Kreem, A.S.; Mohamed, 
A.A. and Fawzy, H. G. (2014): 
Molecular differentiation and 
phylogenetic analysis of the Egyptian 
foot-and-mouth disease virus SAT2. 
Arch Virol, 159(3): 437-443. 
84 
[25] Thomson, G.R.; Vosloo, W. and Bastos 
A.D. (2003): Foot and mouth disease in 
wildlife. Virus Res, 91: 145-161. 
[26] Meyer, R.F. and Knudsen, R.C. (2001): 
Foot-and-mouth disease: a review of the 
virus and the symptoms. J Environ 
Health, 64(4): 21-23. 
[27] Alexandrov, T.; Stefanov, D.; Kamenov, 
P.; Miteva, A.; Khomenko, S; Sumption, 
K.; Meyer-Gerbaulet, H. and Depner, K. 
(2013): Surveillance of foot-and-mouth 
disease (FMD) in susceptible wildlife 
and domestic ungulates in Southeast of 
Bulgaria following a FMD case in wild 
boar. Vet Microbiol, 166(1): 84-90. 
[28] Madhanmohan, M.; Yuvaraj, S.; 
Nagendrakumar, S.B.; Srinivasan, V.A.; 
Gubbins, S; Paton, D.J. and Parida, S. 
(2014): Transmission of foot-and-mouth 
disease virus from experimentally 
infected Indian buffalo (Bubalus bubalis) 
to in-contact naive and vaccinated Indian 
buffalo and cattle. Vaccine, 32(39): 
5125-5130. 
[29] Constable, P.D.; Hinchcliff, K.W.; Done, 
S. and Gruenberg, W. (2017): Veterinary 
Medicine 11th Edition: A textbook of the 
diseases of cattle, horses, sheep, pigs and 
goats - two-volume set. Elsevier Health 
sciences, Philadelphia, PA USA. 
[30] Kitching, R.P. (2002): Identification of 
foot and mouth disease virus carrier and 
subclinically infected animals and 
differentiation from vaccinated animals. 
Rev Sci Tech, 21(3): 531-538. 
[31] Reid, S.M.; Parida, S.; King, D.P.; 
Hutchings, G.H., Shaw, A.E., Ferris, N. 
P.; Zhang, Z.; Hillerton, J. E. and Paton, 
D. J. (2006): Utility of automated real-
time RT-PCR for the detection of foot-
and-mouth disease virus excreted in 
milk. Vet Res, 37(1): 121-132. 
[32] Geering, W.A. and Lubroth, J. (2002): 
Preparation of Foot-and-Mouth Disease 
Contingency Plans. Food and Agriculture 
Organization, Rome: 39-57. 
[33] Martinez, S.C. and Quintero, M. (1998): 
Use of liquid phase ELISA kit for 
detection of antibodies against food-and-
mouth disease virus (FMDV) in 
Colombia International Atomic Energy 
Agency, Vienna (Austria); Food and 
Agriculture Organization of the United 
Nations, Rome (Italy): 29: 554-555. 
[34] Wekesa, S.N.; Sangula, A.K.; Belsham, 
G.J., Tjornehoj, K.; Muwanika, V.B.; 
Gakuya, F.; Mijele, D. and Siegismund, 
H. R. (2015): Characterisation of recent 
foot-and-mouth disease viruses from 
African buffalo (Syncerus caffer) and 
cattle in Kenya is consistent with 
independent virus populations. BMC Vet 
Res, 11(1): 17. 
[35] Klein, J. (2009): Understanding the 
molecular epidemiology of foot-and-
mouth-disease virus. Infect Genet Evol, 
9(2): 153-161. 
 
 
 
 
 
 
 
 
 
 
 58
 الملخص العربى
 محافظة الشرقية بمصروبائية لعدوى فيروس مرض الحمى القلاعية بين الأبقار والجاموس في  رؤي
 
  3صالحعبد اللطيف أيمن  و2أيمن محمد مجاهد، 1شيماء محمد جلال محمد منصور، 1أحمد السيد عبدالحليم عرابى
 
 مصــــــــر -الزقازيق -جامعة الزقازيق -كلية الطب البيطرى -قسم الفيرولوجيا 1
 مصــــــــر -الزقازيق -زيقجامعة الزقا -كلية الطب البيطرى -قسم الصحة العامة البيطرية 2
 مصــــــــر -الزقازيق -جامعة الزقازيق -كلية الطب البيطرى -قسم تنمية الثروة الحيوانية 3
 
يعد مرض الحمي القلاعية من الامراض المتوطنة في جمهورية مصر العربية وكذلك في معظم أجزاء قارة افريقيا 
الحمي القلاعية باستخدام اللقاحات، من الضروري الحصول علي  مسببا خسائر إقتصادية ضخمة. للسيطرة علي مرض
 معلومات عن وبائيات الانواع المصلية المختلفة للفيروس المسبب للمرض. وبناء عليه تهدف هذه الدراسة الي تحديد مدي
عينة (من عشرة  346 مصر. تم تجميع –انتشار الانواع المصلية المختلفة لفيروس مرض الحمي القلاعية في محافظة الشرقية 
حيوان) مختلفة في أعمارها و جنسها وحالتها المناعية ضد مرض الحمي القلاعية و  382أماكن مختلفة) من ابقار وجاموس (
عينة حقلية باستخدام اختبار انريم البلمرة المتسلسل  063كذلك حالتها الصحية. تم عمل مسح لفيروس مرض الحمي القلاعية لـ 
كذلك تم تصنيف الانواع المصلية للفيروس باستخدام بوادئ العكسي وذلك باستخدام بوادئ محددة عالميا و ذو انزيم النسخ
عينة مصلية باستخدام اختبار الاليزا المحدد  382مخصصة للانواع المصلية المختلفة. بالاضافة الي ذلك، تم تحليل عدد 
ة المتسلسل ذو للاجسام المضادة الخاصة بكل نوع مصلي من فيروس مرض الحمي القلاعية. وباستخدام اختبار انريم البلمر
) حيوان قد اعطوا نتيجة %7.44( 83/71) و %6.12( 382/16) و %8.31( 832/93انزيم النسخ العكسي، وجد مجموع 
. وباستخدام اختبار الاليزا، تم علي التوالي 2TASو  Aو  Oايجابية لفيروس مرض الحمي القلاعية من النوع المصلي 
 382/771 في 2TASو  Aو  Oيروس مرض الحمي القلاعية من النوع المصلي لفالتعرف علي الاجسام المضادة المعادلة 
توطن وقد خلصت نتائج هذه الدراسة الي ) حيوان على التوالي. %1.17( 83/72) و %4.06( 382/171) و %5.26(
ضد المرض. ة في محافظة الشرقية علي الرغم من برامج التحصينات الدوري الثلاثة أنواع المصلية لمرض الحمي القلاعية
بالرغم من وجود تباينات عدة في مدي انتشار المرض بين الحيوانات المختلفة في اعمارها وجنسها وحالتها المناعية والصحية 
عنه بين قطعان  )%1.74(الا انه كان من الواضح ان مرض الحمي القلاعية اكثر ضراوة وانتشار بين قطعان الجاموس 
مجهودات المبذولة للسيطرة علي المرض يجب ان توجه للحد من انتشار فيروس مرض الحمي . لذلك فان ال)%1.43(الابقار 
القلاعية بين قطعان الماشية القابلة للاصابة بالمرض مع توجيه اهتمام خاص لقطعان الجاموس المائي. بالاضافة الي المسح 
س مرض الحمي القلاعية والذي يعتبر من المتطلبات المستمرعلي المستوي الجزيئي والمناعي للانواع المصلية المختلفة لفيرو
  الضرورية لتفعيل اي استراتيجية توجه للسيطرة علي المرض بما في ذلك استخدام اللقاحات.
 
 
 
